Literature DB >> 3385512

Flash labelling of S-phase cells in short-term organ culture of normal and pathological human endometrium using bromodeoxyuridine and tritiated thymidine.

J G Thornton1, M Wells, W J Hume.   

Abstract

Normal hyperplastic and malignant endometrial specimens were labelled in vitro with bromodeoxyuridine (BrdU). S-phase cells were stained after DNA denaturation, using a monoclonal antibody to BrdU and an indirect immunoperoxidase method. Various conditions for BrdU uptake, DNA denaturation, and staining were tested. BrdU labelling was compared with autoradiography using tritiated thymidine, with good correlation. Glandular labelling indices of proliferative endometrium were significantly higher than both secretory and hyperplastic endometrium but were similar to carcinoma. Stromal labelling showed the same trend but the differences were not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385512     DOI: 10.1002/path.1711540407

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

Review 1.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

2.  Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria.

Authors:  H Pickartz; R Beckmann; B Fleige; W Düe; J Gerdes; H Stein
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 3.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

4.  In vivo bromodeoxyuridine incorporation in normal mouse kidney: immunohistochemical detection and measurement of labelling indices.

Authors:  H Robertson; J Wheeler; A R Morley
Journal:  Histochem J       Date:  1990-04

5.  In vitro bromodeoxyuridine labelling of renal biopsy specimens: correlation between labelling indices and tubular damage.

Authors:  K V Prasad; J Wheeler; H Robertson; W H MaWhinney; M I McHugh; A R Morley
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

6.  Proliferation indices as molecular pharmacodynamic endpoints in evaluation of anticancer drug effect in human solid tumors.

Authors:  J R Weaver; Y Gan; J L Au
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

7.  Epidermal growth factor receptors in idiopathic and virally induced skin diseases.

Authors:  L B Nanney; D L Ellis; J Levine; L E King
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

8.  Anti-glomerular basement membrane glomerulonephritis (anti-GBM GN) in the mouse: BrdU-labelling indices and histological damage.

Authors:  J Wheeler; H Robertson; A R Morley; D R Appleton
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

9.  Does ex vivo labelling of proliferating cells in colonic and vaginal mucosa reflect the S-phase fraction in vivo?

Authors:  S L Wanders; J ten Kate; E van der Linden; J Derhaag; W N Dinjens; F T Bosman
Journal:  Histochemistry       Date:  1992-11

Review 10.  Measuring proliferation in breast cancer: practicalities and applications.

Authors:  Mark J Beresford; George D Wilson; Andreas Makris
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.